The Sexually Transmitted Infection (STI) array is the broadest multiplex cartridge-based STI test on the market simultaneously detecting 7 bacterial, 2 viral and 1 protozoan infection for a comprehensive sexual health profile.
Globally, each day over 1 million people are exposed to an STI, many of who will not know they have an infection as many STI’s are asymptomatic whilst some individuals will display similar or overlapping symptoms, therefore co-infections may remain undiagnosed. Designed to offer a complete sexual health profile with an aim of prevention and control, the Vivalytic STI array can be used to diagnose existing infections whilst any identifying co-infections.
To find out more about the global economic burden of STIs and the impact of the COVID-19 pandemic on sexual health, download our most recent whitepaper that presents issues such as AMR, the development of super-gonorrhoea, and the challenges faced in a social and public concept due to the COVID-19 pandemic.
Comprehensive Sexual Health Profile
Detecting 10 bacterial, viral and protozoan infections
The STI array has recently received CE marking
Rapid turnaround time of just 2 hours 20 minutes from sample entry to result
Sample to answer, cartridge based molecular diagnostics at the point of care. Powered by Randox Biochip Technology
Simple and easy to use analyser with a small footprint making it suitable for use in laboratory and non-laboratory settings
Convenient 4 step process from sample entry to results. No laboratory training required
Vivalytic Workflow
Intuitive engineering of Vivalytic ensures the analyser is user friendly.